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concludes that the malignancies associ-
ated with EBV infection and especially the 
autoimmune diseases associated with EBV 
infection may result from human genetic 
variations that cause the host to  differentially 
modulate the immune response to EBV 
infection to the detriment of the host.
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A commentary on
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In her review using the human Epstein–
Barr virus (EBV) as an example, Dr. Chen 
intends to illustrate how host immune sys-
tems have evolved in response to pathogens 
or in many cases co-evolved with patho-
gens. She discusses why EBV in most peo-
ple causes what appears to be a self-limiting 
lymphoproliferative disease (or is it? See 
her discussion of autoimmune diseases 
and EBV), but in a very small proportion 
of individuals the virus causes malignant 
diseases of severe consequence. She reviews 
some of the plausible explanations that may 
include interactions of environmental and 
host genetic factors resulting in EBV asso-
ciated malignancies. She points out that 
EBV may not merely transform B cells, 
but it could also impact the host immune 
system on a much more global basis than 
previously realized. She also suggests that 
EBV associated diseases, in lieu of reflect-
ing the pathogenic potential of the virus, 
are actually a reflection of the genetic pre-
disposition of certain populations to the 
modulate immune system inappropriately 
in response to the virus infection. She sup-
ports this notion by detailing the abnormal 
modulation of NKT cells when the host is 
infected with EBV. For example, she cites 
a study that shows that the frequencies of 
regulatory CD8 + NKT, but not CD4 + NKT 
cells, in EBV associated Burkitt’s lymphoma 
(BL) and nasopharyngeal carcinoma (NPC) 
patients are much lower than CD8 + NKT 
levels in healthy EBV carriers (Yuling et al., 
2009), concluding that a skewed NKT cell 
response might modify the pathogenesis 
caused by the virus. She also supports her 
supposition that EBV pathogenesis is likely 
due to improper immune modulation 
in response to the infection by reviewing 
the data associating autoimmune diseases 
with EBV infections, especially focusing on 
multiple sclerosis (MS). She cites a study by 
Serafini et al. (2007) in which it was found 
that that almost 100% of the early onset MS 
cases with the secondary progressive phase 
contain dysregulated EBV infected plasma 
cells in MS brains. She also reviews other 
studies that describe atypical responses of 
MS patients who have been exposed to EBV. 
Nevertheless, the cause and effect link, EBV 
to MS, is still tenuous, yet intriguing. She 
